medtech

Advanced research instrumentation specialists Oxford Optronix to showcase solutions at The Genes & Cancer Meeting in Cambridge,

Abingdon, UK, 17th March 2015 – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces that it will be showcasing its full range of cancer research solutions at The Genes & Cancer Annual Meeting at Robinson College, Cambridge, UK, from 13 - 15 April 2015.

Oxford Optronix will be exhibiting throughout the two-day event, which is now in its 31st year and is the longest-running cancer research meeting in the UK. The Oxford Optronix team will demonstrate its full range of advanced instrumentation products, including the next-generation OxyLite™ dissolved oxygen (pO2) and temperature monitors, the GelCount™ colony counter platform for cancer biologists and its recently launched HypoxyLab™ hypoxia workstation.

Advancing the frontiers of cancer research

Abingdon, UK, 23rd April 2014 – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today releases a new whitepaper outlining the potential of automated colony counting and imaging systems for making major advances in cancer research.

“Advancing the frontiers of cancer research: automated colony counting for cancer biologists” is freely available for download now from the Oxford Optronix website: http://www.optronix1.com/white-paper/

In the wake of recent landmark discoveries into the molecular and biological changes underlying cancer development, laboratories are attempting to manage “industrial scale” research alongside increasingly restrained budgets from public and private funding bodies. The emergence of three dimensional arrays have only added to these pressures, as manually colony counting these complex in vitro culture systems is proving too labour intensive for laboratories to handle.

geneOnyx™ Earns Frost & Sullivan 2013 European New Product Innovation Award in Personalized Cosmeceuticals

London, United Kingdom, May 15, 2013 – geneOnyx™, a provider of over-the-counter cloud-based genetic analytics services for cosmetics and skincare applications, today announces that it has received leading global analyst firm Frost & Sullivan’s 2013 European New Product Innovation Award in Personalized Cosmeceuticals. The prestigious award was formally made at Frost & Sullivan’s 2013 European Growth, Innovation & Leadership Awards Banquet held in London on 14 May.
The innovation of geneOnyx’s world-first over-the-counter DNA anti-ageing test in a retail setting—successfully trialled at Imperial College London in 2012, ahead of a major global commercial launch later this year—was recognised by Frost & Sullivan’s global research organisation of 1,800 analysts and consultants monitoring 300 industries and 250,000 companies.

geneOnyx partners with DNA Electronics to Debut Worlds First On-The-Spot computer microchip DNA Skincare Test at The Organic Pha

London, United Kingdom, October 11th 2012 – geneOnyx™, a provider of over-the-counter cloud based genetic analytics services for cosmetics and skincare applications, today announces the world’s first on-the-spot DNA skincare test, debuted at The Organic Pharmacy’s flagship UK store. geneOnyx™ has partnered with DNA Electronics Ltd., a developer of semiconductor solutions for real-time DNA and RNA detection, to apply the geneOnyx™ cloud recommendations system to a range of highly active anti-ageing skincare products at the leading health and beauty clinic and store – providing rapid results, without the need to send genetic samples away to a lab. The service is available as an in-store treatment to The Organic Pharmacy customers at the Kings Road store in London.

Real-Time Physiological Patient Data Provider IsansysLifecare Makes Its Company Debut

IsansysLifecare Limited, the single-source provider of complete real-time physiological patient data acquisition systems and services, today announces its official debut as a company. The new business, which will focus on providing continuous, real-time patient data to healthcare professionals using the IsansysLifecarePlatform is being headed by Chief Executive Officer and Co-Founder Keith Errey, the high-profile former CEO and Co-Founder of wireless body monitoring technology innovators Toumaz.

Taxonomy upgrade extras:

Subscribe to RSS - medtech